JPRN-UMIN000007520
Completed
Phase 2
Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites. - Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Advanced biliary tract cancer with carcinomatous ascites
- Sponsor
- The University of Tokyo
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with synchronous or metachronous concomitant malignancies 2\) Patients with uncontrolled diabetes mellitus 3\) Patients with uncontrolled hypertension 4\) Patients with renal failure undergoing hemodialysis 5\) Patients with prior myocardial infarction or unstable angina within 6 months 6\) Patients with liver cirrhosis 7\) Patients with intestinal pneumonia, pulmonary fibrosis, and severe pulmonary emphysema 8\) Pregnant or lactating female and patients who is considering pregnancy 9\) Patients with contraindication for S\-1 or paclitaxel 10\) Inappropriate patients for entry on this study in the judgement of the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 and intraperitoneal infusion of nafamostat mesilate for gastric cancer with peritoneal disseminatioGastric cancer with peritoneal disseminationJPRN-UMIN000018658The Jikei University School of Medicine18
Completed
Phase 2
The efficacy and the safety of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced pancreatic cancer with carcinomatous ascites.Advanced pancreatic cancer with carcinomatous ascites.JPRN-UMIN000005306The University of Tokyo30
Active, not recruiting
Not Applicable
ear Ifrared imaging of peritoneal metastasis of colon cancer origine.EUCTR2013-000653-42-BEJules Bordet Institute
Active, not recruiting
Phase 1
Feasibility study of the (intravenously injected) Indocyanine green (ICG) imaging of tumoral implants in patients with peritoneal carcinomatosis from ovarian carcinomaEUCTR2013-000276-15-BEJules Bordet Institute
Not yet recruiting
Phase 3
Implementation and evaluation of an intravenous iron intervention for pregnant women with anaemia: a demonstration projectAnaemiaIron deficiencyPregnancyBlood - AnaemiaReproductive Health and Childbirth - Antenatal careReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12623001163695International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)2,000